1-3 of 3 results for subject:Patients
Librarians' tools
- Search time
- 0.143 seconds
- Solr query time
- 0.003 seconds
- Search query
- subject:Patients
- We searched for
- subject_t:Patients OR subject_t:"Sick people" OR subject_ses:92375
Type
House
Session
Year
Department
Member
More
Primary member
Answering member
Legislative stage
Legislation
Subject
Publisher
To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential merits of offering covid-19 vaccination to patients before planned in-patient hospital surgeries.
To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential merits of offering covid-19 vaccination to patients before planned in-patient hospital surgeries.
Timing of vaccinations for vulnerable patients before planned in-patient hospital surgeries, who are not eligible for a vaccination under phase one prioritisation, is a decision for clinicians responsible for their care. The clinicians would take into account their risk of contracting COVID-19, relative to the potential impact of the vaccine on their treatment.
To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that GPs offer face-to-face appointments to patients during the covid-19 outbreak.
To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that GPs offer face-to-face appointments to patients during the covid-19 outbreak.
NHS England and NHS Improvement have issued guidance on the importance of continuing to offer face to face appointments, utilising remote triage and making use of online and telephone consultations where appropriate – whilst considering the needs of those unable to access or engage with digital services. On 7 January 2021 NHS England and NHS Improvement set out further details on the actions to release capacity in general practice as well as priorities for the next quarter. This includes maintaining routine appointments, supporting the clinically extremely vulnerable and those with ‘long’ COVID-19 and continuing to reduce the backlog of appointments.
To ask the Secretary of State for Health and Social Care, with reference to the study of covid-19 vaccine responses in cancer patients conducted by King’s College and the Francis Crick Institute with preliminary findings reported in March 2021, what assessment he has made of the potential merits of reducing...
To ask the Secretary of State for Health and Social Care, with reference to the study of covid-19 vaccine responses in cancer patients conducted by King’s College and the Francis Crick Institute with preliminary findings reported in March 2021, what assessment he has made of the potential merits of reducing...
The findings of the study, which has not yet been published or peer-reviewed, should be used cautiously as they are indicative and do not provide suitable data to infer directly the level of clinical protection. It should be noted that antibody expression following vaccination may only be part of the protection afforded by the vaccine. For example, the Pfizer/BioNTech vaccine induces a weak antibody response after first dose in the elderly, but recent Public Health England data shows strong clinical protection against hospitalisation and mortality in the same age group.